Most teams face the same problem: too much research, not enough time to use it well. Rev exists at the intersection of scientific rigor and commercial reality — bringing PhD-level expertise, a purpose-built AI pipeline, and deep experience in nutrition and early life health to every engagement. We don't just deliver research. We integrate with your team as the scientific backbone you need, when you need it — translating complex evidence into defensible decisions that move your business forward. From claims substantiation to regulatory positioning to fractional scientific leadership, Rev provides the expertise and infrastructure to turn science into strategy.
We work with companies at every stage — from pre-revenue startups building their first evidence -backed product to nine-figure multinationals managing complex, multi-market scientific programs.
Science done right pays for itself. Rev helps companies avoid the costly errors that come from weak evidence foundations — flawed claims that don't survive regulatory scrutiny, products delayed by insufficient substantiation, strategies built on research that can't be defended. On the other side, rigorous science accelerates growth: faster time to market, stronger claims, and the scientific authority that builds lasting credibility with regulators, healthcare professionals, and consumers.
For startups and early-stage companies, Rev also connects you with the right subject matter experts — scientists, advisors, and industry specialists who help you move faster and smarter without building an expensive internal team from scratch.
Science isn't just a cost center. In the right hands it's a competitive advantage.
Consumer AI tools are general-purpose and optimized for fluency, not scientific accuracy. When you upload a paper to ChatGPT or Gemini, the model generates a statistically likely representation of what it contains — it is not retrieving facts, verifying findings, or checking its output against the source. The result can look authoritative while quietly drifting from what the evidence actually says.
CLARA is a purpose-built pipeline designed specifically for evidence work that has to hold under regulatory and scientific scrutiny. The workflow enforces fidelity to source material, traceability at every step, and human scientific judgment where interpretation is required — none of which general-purpose tools provide by default. Built on scientific principles rather than general-purpose tools, CLARA is the difference between evidence you can defend and evidence that only looks defensible.
No. CLARA accelerates the work — it does not replace the judgment. Every deliverable Rev produces is owned, reviewed, and validated by PhD scientists who understand the regulatory, commercial, and scientific context your evidence has to survive. AI handles the volume. Scientists handle the meaning. That distinction is not a footnote in how we work — it is the foundation of it.
When your evidence foundation can be trusted, your team can focus on what matters — making decisions, not managing data. CLARA builds and maintains living databases that are source-traceable, consistently structured, and scientifically validated, so your team spends less time questioning the evidence and more time acting on it. Rev integrates directly with your team as the research backbone you need — so science moves at the speed of your business.
Yes — when the workflow is built correctly. Regulators including the FDA are increasingly formalizing expectations around AI use in evidence work, emphasizing traceability, validation, and human oversight. CLARA's workflow is designed around exactly these principles, producing outputs with documented audit trails that can withstand external challenge.
Every extraction is traceable back to its primary source. Outputs are validated against original documents before they move into interpretation or synthesis. Nothing enters a claims foundation, regulatory package, or strategic recommendation without PhD-level scientific review.
CLARA is designed for the full range of scientific literature — primary studies, systematic reviews, meta-analyses, grey literature, and regulatory guidance documents. Each document type requires a different extraction approach, and CLARA's workflow accounts for the specific failure modes of each.
Yes. Your data never leaves Rev's server. Each client's data is handled in complete isolation — your proprietary research is never mixed with or accessible to other clients. CLARA is built on commercial API infrastructure, not consumer AI tools like ChatGPT or Gemini — meaning your confidential materials stay within Rev's controlled environment at all times.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.